using iodixanol (Sigma-Aldrich) density gradients (Zolotukhin et al., 1999 (link)). To reduce iodixanol thickness for intravenous
injection, AAV vectors were diluted in phosphate-buffered saline (PBS)/5% sorbitol at a
ratio of 5:1. AAV vectors were also produced by Virovek in insect cells using the
baculovirus expression system (Chen, 2008 (link)). AAV
vectors from Virovek were purified using cesium chloride gradients and diluted in PBS
containing 0.001% pluronic F-68 (Sigma-Aldrich) for intravenous injection. Mice were
intravenously injected via the tail vein with 4 × 1011 viral genomes of
each vector unless otherwise specified. Vector injections were performed slowly and the
volume was limited to 300 μL for tail vein injection and 50 μl for
intrahepatic injection.